Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300158.SZ

SELLREMOVE

Shanxi Zhendong Pharmaceutical Co.,Ltd · Healthcare · China · $738M · Avg Vol: $10M/d

34
StockRank
Q
39
V
48
M
39
P/E (TTM)
ROE
-8.8%
D/E
0.1x
Dividend %
AI CONVICTION THESIS

Shanxi Zhendong Pharmaceutical manufactures traditional Chinese medicines and generic pharmaceuticals. It operates in a highly regulated domestic market subject to government-mandated volume-based procurement price cuts, destroying its pricing power.

COMPANY DESCRIPTION

Shanxi Zhendong Pharmaceutical Co., Ltd. researches, manufactures, and markets traditional Chinese medicines (TCM), chemical generics, and oncology drugs. The company is a market leader in specialized therapeutic areas such as oncology supportive care and hair loss treatments. Its competitive moat is supported by a vertically integrated TCM supply chain, spanning raw herb cultivation to clinical distribution, and a robust domestic sales network.

FINANCIAL SUMMARY (USD)

Year2021202220232024CAGR
Revenue753M551M536M439M-16.4%
EPS0.38-0.01-0.01-0.19
Shares1.0B1.0B1.0B1.0B-2.2%
Debt46M3M421,8476M-49.1%
Equity1.2B777M765M546M-22.9%
Op CF42M13M-37M-22M-69.7%
Inv CF52M354M70M6M
Fin CF-57M-440M-21M-14M
Loading...
PRICE (1M)-17.1%
0.730.770.810.850.89May 6May 27Jun 16
SMA 50SMA 200
Close
$0.74
RSI (14)
51.1
52W High
$1.52
From 52W High
0.5%

SCORE BREAKDOWN

Quality
39
ROIC
-35.2%19.4
ROE
-8.8%36.2
GP/Assets
27.7%61.1
Op. Margin
-0.6%35.2
FCF/Assets
-6.4%33.3
Piotroski
7.2
Int. Cover
-50.0x6.5
D/E Ratio
0.08x69.7
Current Ratio
2.32x43.0
Value
48
P/E (TTM)
N/A
EV/EBITDA
-22.8x88.0
P/FCF
N/A
P/B
1.5x66.3
P/S
1.9x70.0
Div Yield
N/A
Momentum
39
52W High %
48%22.0
RS 6M
-32%38.7
SMA 50/200
0.88x27.4
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
90.2
Q Growth
N/A

FUNDAMENTALS

Market Cap
$738M
P/E (Forward)
12.3x
Gross Margin
51.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300158.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
300158.SZShanxi Zhendong Pharmaceutical Co.,Ltd(you)$738M34SELL
002728.SZTeyi Pharmaceutical Group Co.,Ltd$671M32SELL
002793.SZLuoxin Pharmaceuticals Group Stock Co., Ltd.$690M31SELL
301277.SZNewland Pharmaceutical Co., Ltd.$574M34SELL
688247.SSSinotherapeutics Inc.$571M33SELL
002688.SZJinhe Biotechnology CO., LTD.$628M39HOLD
300267.SZHunan Er-Kang Pharmaceutical Co., Ltd$1.1B34SELL
688176.SSJiangsu Yahong Meditech Co., Ltd.$961M30SELL
002907.SZChongqing Pharscin Pharmaceutical Co., Ltd.$765M26SELL
002038.SZBeijing SL Pharmaceutical Co., Ltd.$893M28SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ) — Stock Score Summary

Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ) has a MoatMap StockRank of 34/100 based on Quality (39/100), Value (48/100), and Momentum (39/100) factor scores. The current signal is SELL. Shanxi Zhendong Pharmaceutical manufactures traditional Chinese medicines and generic pharmaceuticals. It operates in a highly regulated domestic market subject to government-mandated volume-based procurement price cuts, destroying its pricing power.

Shanxi Zhendong Pharmaceutical Co., Ltd. researches, manufactures, and markets traditional Chinese medicines (TCM), chemical generics, and oncology drugs. The company is a market leader in specialized therapeutic areas such as oncology supportive care and hair loss treatments. Its competitive moat is supported by a vertically integrated TCM supply chain, spanning raw herb cultivation to clinical distribution, and a robust domestic sales network.

Key Financial Metrics

Price$0.74
Market Cap$738M
P/E (Forward)12.32
Price/Book1.50
Return on Equity-8.8%
Return on Invested Capital-35.2%
Debt/Equity7.55
Gross Margin51.2%
Operating Margin-0.6%
Revenue Growth-14.0%
Free Cash Flow$-7M

Shanxi Zhendong Pharmaceutical Co.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shanxi Zhendong Pharmaceutical Co.,Ltd’s (300158.SZ) StockRank?
MoatMap’s StockRank for Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ) is 34/100, with a Sell signal. It is a composite of Quality (39), Value (48), and Momentum (39) factor ranks across MoatMap’s 20,000+ stock universe.
Does Shanxi Zhendong Pharmaceutical Co.,Ltd have an economic moat?
Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shanxi Zhendong Pharmaceutical Co.,Ltd a buy, hold, or sell?
MoatMap’s current signal for Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ) is Sell, based on a StockRank of 34/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shanxi Zhendong Pharmaceutical Co.,Ltd in?
Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).